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1. Introduction 
Adenosine has been shown to have a number of 
actions on the cardiovascular system [l-4]. It relaxes 
smooth muscles resulting in dilation of coronary 
arteries and exercises a local control of blood flow in 
relation to myocardial oxygen needs [5,6]. 
It is not known how adenosine causes vasodilation 
and how it exercises its effects on vascular smooth 
muscle. However, adenosine has been shown to aug- 
ment the intracellular CAMP level in the ventricular 
myocardium [6]; moreover, in a number of tissues it 
has been possible to demonstrate direct stimulation 
of adenylate cyclase by adenosine [7]. 
On the other hand, CAMP and adenosine appear to 
be interrelated also at the level of recently discovered 
CAMP-adenosine binding factors [S-lo], among which 
the binding activity of the mouse liver protein, that 
depends on a process of ‘activation’ which has already 
been described in some detail [lo]. Therefore we 
searched directly for a protein capable of binding 
CAMP and adenosine in the heart, a tissue in which 
adenosine is thought to act as a physiological regula- 
tor. 
Here we report the purification by affinity chro- 
matography to apparent homogeneity of a CAMP- 
adenosine binding protein from the soluble fraction 
of rat heart. Recently, data have also been reported 
suggesting that the CAMP-adenosine binding protein 
from human placenta [lo] and mouse liver [ 111 is 
associated with SAH hydrolase activity. The protein 
from rat heart, purified by affinity chromatography, 
was devoid of SAH hydrolase activity. 
Abbreviations: SAH, S-adenosyl-L-homocysteine; Hepes, 
jV-2-hydroxyethylpiperazine-l\i’-2ethanesulfonic acid 
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2. Experimental 
2.1. Materials 
[2-3H]Adenosine (22 Ci/mmol), [8-3H]adenosine 
3’,5’cyclic phosphate (30 Ci/mmol) and adenosine 
5’-[y-32P]triphosphate (13.8 Ci/mmol) were obtained 
from the Radiochemical Centre. Millipore filters 
(HAWP 0.45 pm) were obtained from Millipore S. A. 
All other chemicals were of analytical grade. 
2.2. Thin-layer chromatography 
Thin-layer chromatography was carried out on 
Cellulose F glass plates (Merck) (20 X 20). The chro- 
matographic system used was: n-butanol-methanol- 
water-NH, (60:20: 19: 1). Adenosine (RF 0.6); SAH 
(+ 0.1 5). 
2.3. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis was carried out 
in the absence or presence of sodium dodecyl sulphate 
according to [ 12,131 on 5% polyacrylamide gels. 
2.4. Sucrose density gradient 
The sucrose density gradient centrifugation was 
performed according to [ 141. 
2.5. Assay for SAH hydrolase activity 
The enzyme activity was assayed in the direction 
of synthesis according to [lo]. The reaction mixtures 
contained in 0.05 ml: 100 FM [3H]adenosine; 5 mM 
L-homocysteine (prepared immediately before use by 
mild alkaline hydrolysis of the thiolactone) and 25 
mM potassium phosphate buffer (pH 7.0); containing 
1 mM EDTA and 2 mM 2-mercaptoethanol. The 
reaction was started by addition of the protein. Incu- 
bations were performed for 10 min at 37°C and 
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stopped by addition of 5 ~18 M formic acid. A 
20 ~1 portion was then applied to a Cellulose thin- 
layer cllrornatographic plate along with an unlabeled 
SAH marker and developed as described above. The 
SAH spots were visualized under ultraviolet light, 
scraped off and counted by liquid scintillation. 
sine binding 
Cyclic AMP and adenosine binding activity was 
measured essentially according to [9] as follows. 
Samples (20 ~1) of the solutions to be assayed were 
incubated in presence of 10 FM cyclic [2-3H]AMP 
(0.6 Ci/mmol); 150 mM KC1 and 10 mM magnesium 
acetate in IS mM Hepes buffer (pH 7.0) or 10 PM 
[8-3H]adenosine (1.48 Ci/mmol) and 100 I.IM 
unlabeled CAMP in 1.5 mM Hepes buffer (pH 7.0). In 
the inhibition assays, samples were incubated also in 
the presence of 50 PM 9-~-a~nobenzyl) or 9-(jr- 
aceta~dobenzyl~a~enine in 10% DMSO (tinal). When 
the first steps of purification were assayed, 1 mM 
theophylline was added to inhibit phosphodiesterase 
activity. Incubations were performed at 30°C for 60 
mm in 120 ~1. All incubations were stopped by 
adding 2 mi ce-cold 80% saturated ammonium 
sulphate containing 100 PM unlabeled CAMP or ade- 
nosine. After blending in a Vortex mixer, the protein 
was allowed to precipitate at 0°C for 1 h, then col- 
lected by suction through Millipore filters. The filters 
were washed 3 times with 2 ml 60% saturated ammo- 
nium sulphate and put into scintillation vials. The 
precipitate was dissolved in 1 ml 1% SDS and 10 ml 
Insta-gel were added. 
2.7. Protein assay 
The estimation of protein was based on the method 
in [ 151. Bovine serum albumine was utilized as stan- 
dard. 
2.8. Assay for enzyme activity 
Protein kinase activity was assayed essentially as 
in 1161 by determining the amount of phosphate 
incorporated into histone (2.5 mg/ml) or casein 
(1.5 mgjml) from [y-3’ ]ATP (60 PM). Adenosine 
deaminase activity and nucleoside phosphorylase activ- 
ity were assayed according to [ 171. Phosphodiesterase 
activity was assayed according to [ 181. 
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2.9. Synthesis of the specific adsorbent 
The adsorbent was synthesized by coupling the 
amino group of 9-~-aminobenzyl)adenine to the car- 
boxilate groups of succinylaminopropylaminopro- 
pyl-Sepharose in presence of the water-soluble car- 
bodiimide: cyclohexyl-3-(2-morpholinoethyl)carbodi- 
imide rnethyl-~-toluens~fonate, as described [ 19,201. 
3. Results and discussion 
The preliminary steps of purification of the binding 
protein were carried out according to (91 until DEAE- 
cellulose chromatography as follows: hearts (46 g) 
were frozen into liquid Nz then homogenized in a 
Waring blendor in 1.5 mM Tris-HCl (pH 7.6) con- 
taining 4 mM EDTA and 5 mM 2-mercaptoethanol 
(l/4, w/v). The homogenate was centrifuged for 40 
min at 20 000 X g. The supernatant solution was 
precipitated with polyethylene glycol6000 (11 gf 100 
ml), centrifuged, the pellet discarded and polyethylene 
glycol6000 (13 g/ 100 ml) was again added to the 
supernatant. 
After centrifugation (20 000 X g for 40 min), the 
pellet so obtained was dissolved in 10 mM Tris-HCl 
(pH 7.5) 4 mM EDTA and 5 mM 2-mercaptoethanol. 
The solution was then applied to a DEAE-cellulose 
column (1.6 X 12 cm), equilibrated and eluted with 
the same buffer. The fractions containing the binding 
activity were pooled and exhaustively dialyzed against 
10 mM Tris-HCl (pH 7.2) 4 mM EDTA and 5 mM 
2-mercaptoethanol, Most of the SAH hydrolase activ- 
ity of the crude extract was present in this pool. On 
the contrary, adenosine deaminase activity was absent 
in the pooled fractions after DEAE-cellulose. 
Because 9-@aminobenzyl) and 9-Q-acetamido- 
benzyl)ad~n~e were powerful in~bitors of adenosine 
binding activity (50 f.tM caused an inhibition of 
70% in the standard ‘assay (section 2) we used the 
resin synthesized as above described for purifying the 
binding protein by affinity chromatography. The 
dialyzed solution from DEAE was then applied to the 
affinity column (I .6 X 13 cm) equilibrated with 10 
mM Tris-HC1 (pH 7.2) 4 mM EDTA and 5 mM 
2-mercaptoethanol and exhaustively washed with the 
same buffer. In the washings no binding activity was 
recovered. The protein was then eluted with 4 mM 
guanyl-urea in 10 mM Tris-HCl (pH 8.0) 4 mM 
VoIuma 108, number 2 EEBS LETTERS December 1978 
0.8 
0.7 
0.6 
E 
= 0.5 
0 
Qo 
N 
g 0.4 
a# 
z 0.3 
2: 
=: Cl.2 
f: 
0.1 
5000 
0000 
iOO0 
Fraction number 
Fig.1. Affinity chromatography elution profile for rat heart CAMP-adenosine binding protein. The column (1.6 X 13 cm) was 
equilibrated with IO mM Tris-HCl (pW 7.2) containing 4 mM EDTA and 5 mM 2-mercaptoethanol. Elution was performed using 
4 mM guanykirea in 10 mM Tris-HCI (pH 8.0) 4 mM EDTA and 5 mM 2-mercaptoethanol.~~~* (--). SAH hydrotase activity 
pmol . min-’ . mg-’ . IO3 fA --A). CAMP binding activity (pmof boundfmg protein l - *). Adenosine binding activity 
(pmol bound/mg protein (o----c). 
EDTA and 5 mM 2-mercaptoethanol with a recovery 
of nearly 100%. Guanyf-urea is a powerful inhibitor 
of adenosine binding to the protein (guanyl-urea) (at 
50 PM caused 77% inhibition of adenosine binding 
in the conditions of section 2). In fig.1 the elution 
pattern for th.e CAMP-adenosine binding protein was 
reported. No SAIL hydrolase activity was found in the 
elution peak; all the enzymatic activity present in the 
dialyzed fraction from DEAE was recovered in the 
washings, as shown in fig.1. The fractions containing 
the binding protein eluted with 4 mM guanyl-urea 
were pooled and dialyzed against 10 mM Tris-WC1 
(PH 7.2)> 4 mM EDTA and 5 mM 2-mercaptoetha~~l. 
The washings from the affinity column containing 
SAH hydrolase were incubated in the presence of5 mM 
L-homocysteine and [3H]adenosine under the 
above conditions, except that adenosine was varied 
from 0.3-100 PM. The double reciprocal plot for 
SAN hydro~ase~acti~ty versus the concentration of 
adenosine was linear and consistent with Km 6.5 X IOm7 
M (t&.2), which is in agreement with the value 
reported in [lo]. When assayed in the presence of 
9-~-~~obenzy~)ade~~ne (50 PM), the Knl value 
for adenosine was the same invocating that there is no 
competition for the binding of adenosine to the 
enzyme and that there is no inhibition of SAH hydro- 
lase activity (fig.2). Therefore SAH hydrolase was not 
ret.ained on the affinity column. 
The CAMP-adenosine binding protein from rat 
heart was devoid of adenosme deaminase, nucieoside 
phospho~lase, phosphodiesterase and protein kinase 
activity and shows spec. act. 8800 pmol adenosine 
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Fig.2. Double reciprocal plot for SAH hydrolase activity 
versus the concentration of adenosine. The enzyme activity 
was measured under the conditions in section 2.5; adenosine 
was varied from 0.3-100 PM in the absence (*--5) and 
presence (a- ----A) of 50 PM 9-@-aminobenzyl) adenine. 
bound/mg protein and 5 120 pmol CAMP bound/mg 
protein. The binding protein was purified to apparent 
homogeneity as judged by polyacrylamide gel electro- 
phoresis in the absence and presence of sodium 
dodecyl sulphate. A sharp single band was observed. 
The purified protein sedimented as a sharp single 
peak in a sucrose density gradient. The native protein 
was mol. wt 176 000 (data not shown). Judged by 
SDS-polyacrylamide gel electrophoresis the subunit 
was mol. wt 43 000 (data not shown). These data are 
in agreement with the tetrameric structure previously 
suggested for the mouse liver protein. 
However, it should be noted that the CAMP-adeno- 
sine binding protein and SAW hydrolase from rat 
heart show different structural requirements; in fact, 
the absence of inhibition of SAH hydrolase activity 
by 9-~-~inobe~yi)adenine and, on the contrary, 
the high inhibitory effectiveness of the same com- 
pound towards adenosine binding to the CAMP-ade- 
nosine binding protein, strongly indicates that the 
adenosine binding site of the two proteins differs for 
the purine and ‘not purine’ moieties of the adenine 
nucleoside or its analogues. 
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